Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CASP6 | P55212 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL420648 | 0.87 | CHRM1 (0.36) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL29578118 | 0.87 | CHRM1 (0.36) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL29578091 | 0.86 | CHRNB2 (0.49) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL9403865 | 0.86 | CHRNB2 (0.49) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL237657 | 0.86 | CHRNB2 (0.35) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL236408 | 0.86 | CHRNB2 (0.49) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| SCHEMBL234081 | 0.86 | CHRNB2 (0.35) | CHRNB2CHRNA4CYP11B1ALDH1A1SMN1; SMN2 | |
| SCHEMBL234921 | 0.79 | PARG (0.31) | — | |
| SCHEMBL7172981 | 0.76 | CHRNB2 (0.48) | CHRNB2CHRNA4ALDH1A1SMN1; SMN2CYP3A4 | |
| Thiamethoxam SCHEMBL3956094 | 0.74 | LMNA (0.38) | CHRNB2CHRNA4ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2225940-B1 | Oil dispersions of nAChR binding neonicotinoids | GAT MICROENCAPSULATION GMBH (AT) | 2014-03-12 | — | — | EP | disclosed |
| US-8293733-B2 | Oil dispersions of nAChR binding neonicotinoids | GAT MICROENCAPSULATION AG (AT) | 2012-10-23 | — | — | US | disclosed |
| US-20120004104-A1 | OIL DISPERSIONS OF nAChR BINDING NEONICOTINOIDS | GAT MICROENCAPSULATION AG (AT) | 2012-01-05 | — | — | US | disclosed |
| EP-2225940-A1 | Oil dispersions of nAChR binding neonicotinoids | GAT Microencapsulation AG (AT) | 2010-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004104-A1 | OIL DISPERSIONS OF nAChR BINDING NEONICOTINOIDS | CHRND, ITGAM, CHRM2 | CHRNB2 21/4885CHRNA4 10/4885CYP11B1 2734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.